Angiotensins and Huntington's Disease: A Study on Immortalized Progenitor Striatal Cell Lines

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Neurons in Huntington's disease (HD) models display electrophysiological changes contributing to neurodegeneration.
• The renin-angiotensin system (RAS) is implicated in neurodegenerative diseases, but its specific role in HD remains unclear.
• Angiotensin II (Ang II) and Angiotensin (1-7) are key RAS components with poorly understood functions in HD pathophysiology.

Purpose of the Study:

• To investigate the influence of Ang II and Angiotensin (1-7) on potassium currents in HD models.
• To elucidate the receptor mechanisms underlying these effects in mutant huntingtin-expressing cells.

Main Methods:

• Utilized immortalized progenitor cell lines from wild-type (Q7) and mutant huntingtin-expressing (Q111) mice.
• Measured total potassium current using whole-cell patch-clamp electrophysiology (pCLAMP software).
• Analyzed Ang II AT1 receptor expression via flow cytometry.

Main Results:

• Ang II exhibited negligible effects on potassium current in Q111 cells, unlike Q7 cells, suggesting reduced AT1 receptor function.
• Intracellular Ang II reduced potassium current in Q7 cells but not Q111 cells; losartan abolished Ang II's minor effects.
• Angiotensin (1-7) significantly decreased potassium current in Q111 cells, mediated by Mas receptor activation.

Conclusions:

• Reduced AT1 receptor expression on mutant huntingtin-expressing cells likely explains the negligible response to Ang II.
• Angiotensin (1-7) significantly modulates potassium currents in HD striatal cells through Mas receptor activation.
• These findings highlight differential roles of Ang II and Angiotensin (1-7) in HD neuronal function.